Market Place
Sourcing Support
ICE Pharma joined the fifth edition of “Fabbriche Aperte”
30 Oct 2024 //
PRESS RELEASE
the Ambassador of Italy visits ICE Japan plant
23 Sep 2024 //
PRESS RELEASE
The potential of bile acids as anti-COVID-19 therapies
05 Jan 2024 //
PRESS RELEASE
ICE Pharma attended CPHI India 2023
04 Dec 2023 //
PRESS RELAESE
Bile acids – Thyroid hormone activation
17 Nov 2023 //
PRESS RELEASE
ICE Pharma attended CPHI Barcelona 2023
02 Nov 2023 //
PRESS RELEASE
ICE Pharma will join the fourth edition of the initiative “Fabbriche Aperte” organized by the Piedmont Region
17 Oct 2023 //
PRESS RELEASE
ICE Pharma connects to build a healthier society
06 Oct 2023 //
CPHI-ONLINE
ICE Pharma will develop a 100% recyclabe booth at CPHI Barcelona 2023
28 Sep 2023 //
PRESS RELEASE
ICE Pharma attended EASL congress 2023
04 Jul 2023 //
PRESS RELEASE
ICE Pharma celebrated the first-year anniversary of its acquisition of the UDCA plant in Iwaki
24 May 2023 //
PRESS RELEASE
Check up your bias, Episode 4 – Bias with roles
11 May 2023 //
PRESS RELEASE
Exploring Bile Acid interview with Roger Viney in collab with Pharma Technology
09 May 2023 //
PRESS RELEASE
ICE Pharma developed a new website to offer a comprehensive range of bile acids
05 May 2023 //
PRESS RELEASE
ICE Pharma installed three defibrillators in our plant in Basaluzzo
17 Apr 2023 //
PRESS RELEASE
ICE Pharma has formed its Scientific Advisory Board
03 Apr 2023 //
PRESS RELEASE
ICE Pharma launches the project Check-up your bias to promote gender equality
15 Mar 2023 //
PRESS RELEASE
ICE Pharma will attend the DCAT Week in New York City
13 Mar 2023 //
PRESS RELEASE
Fourth research publication in collab with ICE Pharma & Ferrier Research
06 Feb 2023 //
PRESS RELEASE
ICE Pharma obtained the certifications ISO 45001 and ISO 50001
25 Jan 2023 //
PRESS RELEASE
A recent study suggest that UDCA may help prevent Covid infection
19 Jan 2023 //
PRESS RELEASE
New Zealand Pharmaceuticals achieved the FernMark license
13 Dec 2022 //
PRESS RELEASE
ICE Pharma published the Sustainability Report 2021/2022
02 Dec 2022 //
PRESS RELEASE
ICE Pharma attended CPHI Frankfurt 2022
21 Nov 2022 //
PRESS RELEASE
ICE Pharma acquires Iwaki manufacturing site from Mitbubishi API corporation
03 May 2022 //
PRESS RELEASE
Third research publication in collaboration with ICE Pharma and Ferrier Research
06 Apr 2022 //
PRESS RELEASE
Bile acids in medicine. Review article by ICE Pharma
01 Apr 2022 //
PRESS RELEASE
Second research publication in collaboration with ICE Pharma & Ferrier Research
02 Mar 2022 //
PRESS RELEASE
ICE Pharma acquires ABC Farmaceutici S.p.A.
16 Dec 2021 //
PRESS RELEASE
First research publication in collaboration with ICE Pharma & Ferrier Research
14 Sep 2021 //
PRESS RELEASE
ICE Pharma Cogenerator Project in Basaluzzo manufacturing site
03 Jun 2021 //
PRESS RELEASE
